Camoteskimab (AVTX-007), a fully human, high-affinity anti-IL-18 monoclonal antibody, holds promise for research into autoinflammatory diseases, such as adult-onset Stills disease (AOSD) [1].
CAS Number:
[2492472-82-7]
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted
